高危特征甲状腺乳头状癌行腺叶切除的长期结局
研究纳入2000—2012年连续2059例伴至少一项高危特征的甲状腺乳头状癌(PTC)患者,其中腺叶切除1224例、全甲状腺切除835例。中位随访93个月,多因素分析显示手术范围与疾病特异性生存(DSS)无关(HR 1.36,95%CI 0.75–2.48,P=0.310);1:1匹配528例后,两组10年DSS率(94.3% vs 95.2%,P=0.323)和无复发生存率(75.8% vs 79.2%,P=0.784)均无显著差异。结论认为腺叶切除未与更差结局相关。
要点
- 高危特征PTC中腺叶切除与全甲状腺切除的10年DSS和无复发生存率无显著差异
- 全甲状腺切除组双侧癌、宏观多灶和双侧颈转移比例显著更高
- 多因素分析显示手术范围与DSS无关(HR 1.36,95%CI 0.75–2.48,P=0.310)
核心结论
- 对于伴高危特征的PTC患者,腺叶切除未与显著更差的结局相关。
研究设计与样本
- 研究纳入2000—2012年连续2059例伴至少一项高危特征的PTC患者,其中腺叶切除1224例、全甲状腺切除835例。
- 高危特征定义为原发肿瘤大于4 cm、肉眼甲状腺外侵犯、宏观多灶性、确认淋巴结转移(包括病理侧颈转移pN1b或超过5枚中央淋巴结转移)。
- 采用Cox比例风险模型在全队列和匹配对分析中评估手术范围与DSS的关联。
- 对528例患者进行1:1病例对照匹配。
主要发现
- 全甲状腺切除组双侧癌比例显著高于腺叶切除组(79.4% vs 2.7%)。
- 全甲状腺切除组宏观多灶性比例显著高于腺叶切除组(80.8% vs 32.8%)。
- 全甲状腺切除组双侧颈转移比例显著高于腺叶切除组(30.9% vs 3.3%),所有P<0.001。
- 中位随访93个月,多因素分析显示手术范围与DSS无关(HR 1.36,95%CI 0.75–2.48,P=0.310)。
- 匹配后腺叶切除组与全甲状腺切除组10年DSS率分别为94.3%和95.2%(P=0.323),10年无复发生存率分别为75.8%和79.2%(P=0.784)。
关键数值与推荐
- 高危特征包括原发肿瘤大于4 cm、肉眼甲状腺外侵犯、宏观多灶性、病理侧颈转移(pN1b)或超过5枚中央淋巴结转移。
- 多因素分析HR 1.36(95%CI 0.75–2.48,P=0.310)提示手术范围与DSS无关。
- 匹配后10年DSS率94.3% vs 95.2%(P=0.323),10年无复发生存率75.8% vs 79.2%(P=0.784)。
临床怎么用
- 对于伴高危特征的PTC患者,腺叶切除可作为不劣于全甲状腺切除的手术选择之一。
- 决策时应结合双侧癌、多灶性和淋巴结转移等特征个体化评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lobectomy is not advocated for papillary thyroid carcinoma (PTC) with high-risk features, although there is no high-level evidence showing that this is an inferior strategy. This study aimed to examine the association between the extent of surgery and survival of patients with PTC and high-risk features. METHODS: Consecutive patients with PTC and at least one high-risk feature treated in 2000-2012 were included in the study. High-risk features were defined as: primary tumour larger than 4 cm, gross extrathyroidal extension, macroscopic multifocality, and confirmed nodal metastasis including pathological lateral neck metastasis (pN1b) or more than five central lymph node metastases. Cox proportional hazards models were employed to measure the association between the extent of surgery and disease-specific survival (DSS) in the whole cohort and in a matched-pair analysis. RESULTS: Among a total of 2059 patients with high-risk features, 1224 underwent lobectomy and 835 had total thyroidectomy. Patients who underwent total thyroidectomy had significantly higher rates of bilateral cancer than those who had a lobectomy (79.4 versus 2.7 per cent respectively), macroscopic multifocality (80.8 versus 32.8 per cent) and bilateral neck metastasis (30.9 versus 3.3 per cent) (all P < 0.001). With a median follow-up of 93 months, multivariable analysis showed that the extent of surgery was not associated with DSS in the whole cohort (hazard ratio 1.36, 95 per cent c.i. 0.75 to 2.48; P = 0.310). After 1 : 1 case-control matching of 528 patients, no significant difference between lobectomy and total thyroidectomy groups was observed with respect to the 10-year DSS rate (94.3 versus 95.2 per cent respectively; P = 0.323) or 10-year recurrence-free survival rate (75.8 versus 79.2 per cent; P = 0.784). CONCLUSION: Lobectomy was not associated with significantly worse outcomes for patients with PTC and high-risk features.
引用
- Xu S, Huang H, Wang X, et al. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features. Br J Surg. 2021. PMID: 33793787. doi:10.1093/bjs/znaa129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。